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Excretion of 14C-Fumonisin B1, 14C-Hydrolyzed Fumonisin B1, and
14C-Fumonisin B1-Fructose in Rats
William R. Dantzer,†,‡ Joan Hopper,§ Kathy Mullin,§ Suzanne Hendrich,† and
Patricia A. Murphy*,†
Department of Food Science & Human Nutrition and Laboratory Animal Resources, Iowa State University,
2312 Food Sciences Building, Ames, Iowa 50011
14C-Fumonisin B1 (FB1) was produced by Fusarium proliferatum M-5991 in modified Myro liquid
medium and purified to >95% purity with a specific activity of 1.7 mCi/mmol. Nine male and nine
female F344/N rats were each dosed by gavage with 0.69 ímol of 14C-FB1, 14C-hydrolyzed FB1, or
14C-FB1-fructose/kg body weight. Urinary excretion of 14C-FB1 and 14C-FB1-fructose was 0.5% and
4.4% of the total dose, respectively, and was similar between male and female rats. Urinary excretion
of 14C-hydrolyzed HFB1 was significantly greater (P > 0.05) in female rats as compared with male
rats (17.3% vs 12.8% of the total dose, respectively). There were no significant (P > 0.05) differences
in biliary excretion of the three fumonisin compounds with a mean of 1.4% of the dose excreted at
4 h after dosing. Lesser amounts continued to be excreted up to 9.25 h after dosing. Although biliary
excretion of the 14C-FB1, 14C-hydrolyzed FB1, and 14C-FB1-fructose was similar, increased urinary
excretion of the 14C-hydrolyzed FB1 as compared to 14C-FB1 and 14C-FB1-fructose indicated a greater
absorption of the hydrolyzed form.
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INTRODUCTION
The fumonisins (FBs) are a family of mycotoxins
including FB1, FB2, FB3, and FB4 (Gelderblom et al.,
1988; Cawood et al., 1991) with FB1 predominant. The
FBs are produced by the maize pathogens Fusarium
proliferatum and Fusarium moniliforme. Fumonisin
consumption causes equine leucoencephalomalacia
(Kellerman et al., 1990) and porcine pulmonary edema
(Osweiler et al., 1992; Colvin and Harrison, 1992).
Fumonisins also cause embryopathogenicity in chickens
(Javed et al., 1993), developmental toxicity in hamsters
(Floss et al., 1994), and kidney toxicity and liver cancer
in rats (Gelderblom et al., 1991; Voss et al., 1993).
Sharma et al. (1997) demonstrated in vivo apoptosis in
mouse liver and kidney after doses of 0.35-8.7 ímol of
FB1/kg body weight (bw) were given subcutaneously.
The effects of FBs on humans are not known. But
epidemiological studies show significant correlations
between high levels of FBs in corn consumed by humans
and esophageal cancer (Sydenham et al., 1990; Rheeder
et al., 1992; Chu and Li, 1994). Fumonisin B1 is listed
as a Class 2B carcinogen, a probable human carcinogen
(IARC, 1993).
The study of fumonisin metabolism has been facili-
tated by the production of 14C-FB1, which permits rapid
analysis of the biological disposition of this compound.
Fumonisin B1 has been radiolabeled using 14C-acetate
or -methionine in cultures of F. moniliforme or F.
proliferatum in liquid medium (Norred et al., 1993;
Blackwell et al., 1994; Lebepe-Mazur, 1993). In fasted
rats, Norred et al. (1993) detected 80% and 2.3% of FB1
administered by gavage (1.4 ímol of 14C-FB1/kg bw) in
feces and urine, respectively. Liver, kidney, and blood
retained a total of 0.6% of the dose 96 h after treatment.
In fed rats at 24 h after a dose administered by gavage
(10.4 ímol of 14C-FB1/kg bw), Shephard et al. (1992)
detected 100% and trace levels of FB1 in feces and urine,
respectively. Trace levels of 14C-FB1 were detected in
liver, kidney, and blood of these rats. From these two
studies, FB1 absorption may be greater in fasted rats
than in fed rats. Biliary excretion of FB has been
suggested by observations of fecal recovery of 14C-FB
given by intravenous or intraperitoneal routes (Norred
et al., 1993; Shephard et al., 1992). Shephard et al.
(1994) recovered 67% of an intraperitoneal dose (10.4
ímol of 14C-FB1/kg bw) after 24 h in bile whereas 0.2%
of a 0.4-ímol dose administered by gavage was detected
in bile of fed rats. Other forms of fumonisins such as
hydrolyzed FB1 have not been evaluated for biliary
excretion. Hopmans et al. (1997) analyzed by HPLC the
excretion of unlabeled FB1 at three doses. Administra-
tion of 0.69, 6.93, and 69.3 ímol of FB1/kg bw to fed rats
resulted in 7.4, 1.2, and 0.5% of the dose excreted in
urine, respectively, confirming previous findings with
radiolabeled FB1 but also suggesting dose differences
in absorption.
FB1 may undergo reactions in food systems that alter
its chemical structure and its toxicity. Alkaline hydroly-
sis of FB-containing corn produced hydrolyzed FB1
(HFB), which was found to promote diethylnitrosamine
(DEN)-initiated hepatocarcinogenesis nearly as well as
FB1 when fed to rats (Hendrich et al., 1993). Urinary
excretion of HFB1 was 2-fold greater than FB1 in rats
(Hopmans et al., 1997), suggesting a significant role for
increased bioavailability in HFB1 toxicity as compared
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with FB1. A Maillard-like reaction between FB1 and a
reducing sugar such as fructose can occur during
heating (Murphy et al., 1996). Feeding FB1-fructose
reaction products caused no development of altered
hepatic foci in DEN-initiated rats, whereas an equimo-
lar amount of FB1 promoted hepatocarcinogenesis readily
(Lu et al., 1997). The seeming lack of toxicity of FB1-
fructose product(s) could not be explained by lesser
absorption in Hopmans et al. (1997) because such
products were absorbed to a greater extent than FB1 in
rats, based on relative urinary excretion. A FB1-glucose
reaction product, N-(carboxymethyl)-FB1 has recently
been isolated (Howard et al., 1998), but its toxicity is
unknown. The mechanism of formation and the nature
of the first products in the Maillard reaction are not
well-characterized even after over 50 years of study (Ge
and Lee, 1997). But fumonisin-sugar products might
form during food processing and could diminish or alter
fumonisin toxicity.
This study was designed to determine, with 14C-FB1,
the extent of urinary excretion of the low doses of 0.69
ímol of FB1, HFB1, and FB1-fructose/kg bw used by
Hopmans et al. (1997). We also analyzed biliary circula-
tion of these three forms of fumonisin most likely to be
found in foods.
MATERIALS AND METHODS
Reagents were from Fisher Scientific (St. Louis, MO) unless
noted otherwise. Milli-Q water (Millipore-Waters, Bedford,
MA) was used throughout. All animal procedures and protocols
were approved by the Iowa State University Animal Care and
Use Committee. The FB1 produced from Fusarium cultures is
a class 2B carcinogen and was handled accordingly. We treated
HFB1 similarly. We followed Iowa State University Environ-
mental Health and Safety guidelines for the use of 14C.
The 500-mL liquid cultures of F. proliferatum M5991 were
prepared as in Dantzer et al. (1996a). These cultures were
inoculated with Myro liquid medium (LM), containing MgSO4
at only 0.5 g/L and 1.00% corn hull extract (modified Myro
LM). The inoculum culture was incubated for 4 days on a
rotary shaker at 220 rpm at 25 °C. Aliquots of 0.5 mL of
inoculum were transferred to three replicate rubber-stoppered
125-mL Erlenmeyer flasks containing 50 mL of modified Myro
LM. Compressed air was cleaned by passage through five 2-L
plastic bottles containing air, 2 N KOH, 2 N KOH, distilled
H2O, and 2 N H2SO4, followed by a moisture trap and a 0.2-
ím in-line filter. The purified air was bubbled through the F.
proliferatum-inoculated culture flasks at 0.5 mL/min while the
flasks were shaken on a rotary shaker at 220 rpm and 23 °C
for 30 days. Aliquots of 1 mL were removed from the cultures
every 7 days and frozen at -20 °C until analyzed for FB1.
Glassware was cleaned with Nochromix laboratory glass
cleaner (GODAX Laboratories, Inc, Takoma Park, MD) for >15
min. An 0.5-mL aliquot of a 4-day-old F. proliferatum M 5991
LM culture was transferred to a rubber-stoppered 125-mL
Erlenmeyer flask. Air exiting the culture was passed through
two CO2 traps containing 2 N KOH. The flask was incubated
with shaking at 220 rpm and 23 °C for 10 days. A 100-íL
aliquot of culture was removed to obtain baseline FB1 concen-
tration. The ethanol containing 56 mCi/mmol universally
labeled (U)-14C-acetate (American Radiolabeled Chemicals,
Inc., St. Louis, MO; Lot No. 960214) was evaporated, and the
residue was dissolved in Milli-Q water. Preliminary results
indicated that ethanol decreased production of FB1 and cell
density of F. proliferatum culture. Four equal aliquots of 250
íCi of U-14C-acetate were transferred into the F. proliferatum
culture after 12, 15, 18, and 21 days for a total of 1.00 mCi of
U-14C-acetate. The culture was agitated on a shaker at 220
rpm and harvested at 25 days. The KOH traps were replaced
every 24 h and counted in ScintiVerse BD scintillation fluid
for 4 min using a Packard liquid scintillation analyzer, model
1900TR (Packard Instruments Co., Downers Grove, IL).
14C-Fumonisin B1 purification was performed according to
Dantzer et al. (1996b) with modifications. Briefly, the 50 mL
of 14C-FB1-containing LM was filtered through a Whatman no.
1 filter, followed by 0.8- and 0.45-ím MSi filters (4.5 cm, nylon,
Micron Separations, Inc., Westboro, MA). The 14C-FB1 was
fractionated on XAD-16, C8, DEAE-Sepharose, and C18 col-
umns. The XAD-16 column was 30  2 cm with 50 g of
Amberlite XAD-16 (Sigma Chemical Co., St. Louis, MO). The
XAD column was washed with 150 mL of Milli-Q water
followed by 150 mL of 50% acetonitrile in water. All other steps
were as reported previously. After elution of the FB fraction
from the C18 column, the sample was concentrated by rotary
evaporation at 45 °C, freeze-dried, weighed, rehydrated in 50%
acetonitrile/water, and quantified for FB1. Three aliquots, each
containing 1.39 ímol of 14C-FB1 were taken to dryness by
rotary evaporation at 45 °C and used to prepare 14C-FB1, 14C-
HFB1, and 14C-FB1-fructose doses. The 14C-FB1 dose was
rehydrated in 10 mL of Milli-Q water. The 14C-HFB1 was
prepared by rehydration of 1.39 ímol of FB1 in 5 mL of Milli-Q
water and hydrolysis in a marble-capped test tube with 1 mL
of 2 N KOH for 2 h in a boiling water bath. The pH of the
HFB1 solution was adjusted to <3 with 12 N HCl, loaded onto
a PrepSep P479-C18 extraction column, and washed with 20
mL of Milli-Q water. The HFB1 was eluted with 10 mL of
methanol (Hopmans et al., 1997). The methanol was removed
by rotary evaporation at 45 °C. The 14C-HFB was redissolved
in 10 mL of Milli-Q water. The 14C-FB1-fructose was prepared
by rehydration of 1.39 ímol of 14C-FB1 in 10 mL of 50 mM
K2HPO4, pH 7.0, containing 100 mM D-fructose and heating
at 80 °C for 48 h (Hopmans et al., 1997). Ten percent of
unreacted FB1 remained in the FB1-fructose mixture. The
volume of the FB1-fructose was adjusted to 10 mL with Milli-Q
water. All three 14C-FB forms were stored at -20 °C until use.
The concentrations of 14C-FB1 and -HFB1 were estimated
by HPLC analysis of o-phthaldialdehyde derivative using a
Turner fluorometer (Corning 7-60 primary filter and Wratten
2a secondary filter, 15 íL flow cell) (Dantzer et al., 1996b).
The purity of 14C-FB1 was determined by comparing the
amounts as measured by HPLC with the freeze-dried mass of
the purified 14C-FB1. The 14C-HFB1 was quantified in a similar
manner by comparison with an HFB1 standard curve. The
HFB1 standard was prepared according to Hopmans et al.
(1997). The HFB1 standard was shown to be >95% pure by
FAB-mass spectrometry (Hopmans et al., 1997; Mirocha,
personal communication). Residual FB1 in the 14C-FB1-fructose
dose was analyzed by HPLC (Dantzer et al., 1996b).
Eighteen Fisher 344/NHsd rats, nine male and nine female,
at 7-8 and 9-10 weeks of age (bw 135-160 g), respectively,
were randomly assigned to one of the treatment groups for
the excretion study. All rats were housed individually and
given AIN-93M diet (Reeves et al., 1993) and water ad libitum
for 1 wk under a 12-h light/dark cycle. At the end of a 12-h
light cycle, groups of three males and three females were
administered 0.69 ímol of 14C-FB1, 14C-HFB1, or 14C-FB1-
fructose/kg bw by gavage. The rats were housed individually
in metabolic cages, and fecal and urine samples were collected
at 12-h intervals. At 84 h, the rats were sacrificed by CO2
asphyxiation; blood was drawn by heart puncture; and the
hearts, livers, lungs, kidneys, and brains were removed for 14C
analysis.
For the biliary excretion study, nine female 15-week-old
Sprague-Dawley rats (bw 240-270 g) were used. All rats were
housed individually and given AIN-93M diet and tap water
ad libitum for 1 week under 12-h light cycle. Rats were
anesthetized with 5 mL/kg bw of a 25% urethane (Sigma)
solution intraperitoneally, and their bile ducts were surgically
cannulated with silicone rubber tubing (0.3 mm i.d.  0.6 mm
o.d.; BrainTree Scientific, Braintree, MA). After cannulation,
the abdomen was surgically closed, and 3 rats/treatment were
immediately gavaged with 0.69 ímol of either 14C-FB1, -HFB1,
or -FB1-fructose/kg bw. All rats were placed on their left side
on a hot water heating pad set at medium heat. Bile from each
rat was collected into 1.5-mL graduated microcentrifuge tubes
every 30 min until rats died or were sacrificed 9.5 h after
dosing. Livers, kidneys, stomach washes, stomachs, and the
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first, second, and third sections (I, II, and III) of small
intestines were collected after the rats died or at sacrifice, 9.5
h after dosing. All samples were stored at -20 °C until
analysis.
Fecal samples, oven dried at 60 °C overnight, and intestinal
tissues, frozen in liquid N2, were ground in a porcelain mortar
and pestle. Ground feces, intestinal tissues, stomach, stomach
wash, kidney, liver, lung, brain, and blood were separately
blended in a tissue homogenizer (model TR-10, Tekmar Co.,
Cincinnati, OH) at 60% power for 0.5-1 min in 5 mL of Milli-Q
water, brought to a known volume of 10-35 mL with Milli-Q
water, and quantified for 14C by scintillation analyzer. Quench-
ing of tissues was measured with 0.5-1 mL of tissue extract
with and without 18 400 dpm 14C-FB1. Data were corrected
using percent quenching in the respective sample.
A completely randomized design was used for statistical
evaluation of urine and fecal excretion data in the 18 Fisher
rats and for the biliary excretion data in the 9 Sprague Dawley
rats. Differences among treatments were assessed by a Stu-
dent’s t statistic (P e 0.05) using SAS (version 6.03, 1995, Cary,
NC).
RESULTS AND DISCUSSION
F. proliferatum yielded 1200 ímol of FB1/L between
days 10 and 31 of culture (Figure 1). There was an
average production of 0.18 íCi of 14CO2/h within the first
24-h period after each addition of 250 íCi of 14C-acetate.
The production of 14CO2 decreased to undetectable levels
3 days after each addition of the 14C-acetate at an
apparent logarithmic rate, suggesting that the produc-
tion of acetate by the F. proliferatum culture was
significantly greater than the addition of the labeled
acetate. The culture was harvested at 24 days. The FB1
was purified to >95% purity with a yield of 24 ímol and
a specific activity of 1.7 mCi/mmol. 14C-Fumonisin B1
measurement in biological samples allowed for improved
monitoring of FB1 as compared to HPLC fluorescence
detection. But scintillation counting of 14C-FB1 could not
reveal any information on metabolic modification of FB1
or its related forms.
The doses for the urine and fecal excretion study were
0.14 ímol of 14C-FB1, 14C-HFB1, or 14C-FB1-fructose/mL
with specific activities of 1.7, 1.2, and 1.8 mCi/mmol,
respectively. The lower specific activity of the HFB1
suggested that part of the U-14C-acetate was incorpo-
rated into the tricarboxylic side chains of FB1 that were
removed during hydrolysis to produce HFB1.
Quenching in the blood and liver fractions was
determined to be 86 and 28%, respectively, for added
14C-FB1. All other tissues had negligible quenching (data
not shown). All data were corrected for quenching.
Recently, Howard et al. (1998) identified N-(carb-
oxymethyl)-FB1 as a reaction product of FB1 and glu-
cose. Yaylayan and Huyghues-Despointes (1994) re-
ported that nonenzymatic browning reaction products
from fructose are much more complicated than those
from glucose due to the nature of the products formed
from a ketose. In addition, our reaction time between
FB1 and fructose was 4-fold longer than that reported
by Howard et al. (1998), which probably means that our
FB1-sugar adducts were a much more complex mixture,
as is usually seen with the formation of Amadori
products (Labuza, 1994). For the sake of simplicity in
this paper, we named our fructose-FB1 reaction product
mixture, FB1-fructose. Our limited attempts to identify
the products produced in the FB1-fructose (and -glucose)
model systems by mass spectrometry have been unsuc-
cessful to date. A number of o-phthalaldeyhyde (OPA)
fluorescent peaks were detected in the FB-fructose
reaction mixture, but we would not expect anything
reacting with the FB amine group to be detected by
amine derivatization.
Excretion of 14C in urine over time did not differ
significantly between genders, except for HFB1 during
the first excretion interval [female > male (Table 1)],
so data were combined (n ) 6) (Figure 2). Fifteen
percent, 4.4%, and 0.6% of the total 14C dose was
excreted in urine for HFB1, FB1-fructose, and FB1
respectively (Table 1). The average half-life for excretion
of FB compounds was 10 h. There were only trace
amounts of 14C-FB1 excreted in urine with most of the
urinary excretion occurring in the first 12 h (Figure 2).
The urinary excretion of HFB1 persisted for up to 60 h
after dosing with maximum excretion occurring between
12 and 24 h. The urinary excretion of 14C-FB1-fructose
persisted for 24 h with the maximum excretion occur-
ring in the first 12 h. The pattern of excretion of HFB1
and of FB1-fructose resembled one-compartment models
of elimination. Amounts of 2-5-fold greater 14C-HFB1
than FB1 were excreted in urine, suggesting that HFB1
was better absorbed than FB1 in these rats. Dietary
HFB1 was nearly as toxic as FB1 during the promotion
phase of a two-stage model of rat hepatocarcinogenesis
(Hendrich et al., 1993). Because the similarity between
HFB1 and FB1 in toxicity may be accounted for by the
greater bioavailability of HFB1, FB1 would seem to be
more toxic at the cellular level than HFB1. But in
primary rat hepatocytes, HFBs were more cytotoxic
than FBs as measured by lactate dehydrogenase leak-
age (Gelderblom et al., 1993). The toxic dose of FBs was
1 mM or more in the hepatocyte cultures. Such high
concentrations would be highly unlikely to be achievable
through dietary exposures, given the very limited ap-
parent absorption of FB1. The hepatocyte culture studies
are probably not helpful in explaining FB1 toxicity in
vivo.
Total excretion of 14C-FB1-fructose was 8-fold greater
than FB1, suggesting that FB1-fructose may have greater
bioavailability than FB1 in these rats (Table 1). Fumo-
nisin B1-fructose product(s) seem to be detoxified forms
of FB1 during the promotion phase of a two-stage rat
hepatocarcinogenesis model (Lu et al., 1997). The mech-
anism cannot be due to reduced absorption of FB-
fructose. Blocking the FB amine group prevented tox-
icity in primary rat hepatocyte cultures as well as in
vivo (Gelderblom et al., 1993). Perhaps the blocked
amine group sterically prevents the interaction of FBs
with their molecular sites of action.
Figure 1. Production of FB1 (ímol/L) and 14CO2 (íCi/h) by
Fusarium proliferatum M-5991. Bars represent 14CO2 produc-
tion in 50 mL of modified Myro media spiked with 250 íCi of
U-14C-acetate at days 12, 15, 18, and 21; n ) 1. Line represents
FB1 production (ímol/L); n ) 3.
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The total urinary excretion of 0.69 ímol of HFB1 and
FB1-fructose as compared to FB1 over 84 h was compa-
rable to the previous study over 96 h at three dose levels
(Hopmans et al., 1997). Both studies reported the same
total percent urinary excretion of HFB1 and relative
absorptions of HFB1 and FB1-fructose as compared to
FB1. In the study by Hopmans et al. (1997), rats dosed
with 0.69 ímol of FB1-fructose or FB1/kg bw excreted
4.2% of the total dose of FB1-fructose and 7.4% of the
total dose of FB1 in the urine as compared with 4.4%
and 0.6%, respectively, in our current study. Hopmans
et al. (1997) correlated FB1 and FB1-fructose to the
amount of OPA-HFB1 in the hydrolyzed rat urine.
Hydrolysis of urine produced a free amine group on the
FB1 molecule for OPA derivatization. In the current
study, FB1 and FB1-fructose were measured as the
amount of 14C detected in the rat urine. The differences
in these two studies may reflect a difficulty in accurate
estimation of very small quantities of FBs by sample
extraction and HPLC analysis. Norred et al. (1993)
found that 2-3% of a gavaged dose of 1.4 ímol of 14C-
FB1/kg bw was excreted in the urine of fasted Sprague-
Dawley rats after 96 h, suggesting that their fasted rats
had a greater absorption of FB1 than our rats. Our
dosing of rats occurred at the end of the light cycle. Rats
do not eat much during the light cycle, so our rats should
have been fairly comparable to rats fasted for 12 h. The
apparent higher absorption by Norred’s rats as com-
pared to our rats could be attributed to differences in
strain of rat or, more likely, to differences in absorption
of FBs with the extent of food deprivation. In fed rats,
food may make FBs less available for GI tract absorp-
tion.
The data for fecal excretion of 14C in male and female
rats, dosed with the same compound, were combined
because they were not significantly different according
to gender (Figure 3). The pattern of fecal excretion of
14C-FB1, 14C-HFB1, and 14C-FB1-fructose followed a
normal excretion of a compound through the fecal route
(Casarett and Doull, 1991) with maximum excretion of
14C from the three FB forms between 12 and 24 h. After
60 h, only trace amounts of 14C were recovered in the
feces from these rats. Total fecal excretion was not
significantly different between FB compounds or gender
and averaged 90% recovery of total dose after 84 h
(Table 1).
The total 14C recovered from the hearts, brains, livers,
blood, kidneys, or lungs of rats dosed with 0.69 ímol of
14C-FB1, 14C-HFB1, or 14C-FB1-fructose/kg bw was not
significantly different from zero for all rats, indicating
that accumulation of these compounds did not occur
after 84 h (data not shown).
In the biliary excretion study, Sprague-Dawley rats
were used because the Fisher rats were not large
enough for successful cannulation. The same FB treat-
ments were used for the biliary excretion study as in
the urinary excretion study. However, to obtain proper
volumes, the 0.14 ímol of 14C-HFB1 and 14C-FB1-
fructose/mL treatments were diluted with unlabeled
0.14 ímol of HFB1 or FB1-fructose/mL, which resulted
in specific activities of 0.7 and 1.0 mCi/mmol, respec-
tively. All nine of the cannulated female rats survived
for 4 h after dosing. Biliary excretion of 0.69 ímol of
14C-FB1, 14C-HFB1, or 14C-FB1-fructose/kg bw by female
rats were not significantly different with an average of
1.35% and a range of 0.80 (FB1 -fructose) to 1.17 (HFB1)
of the total 14C dose excreted 4 h after dosing (Table 2).
Biliary excretion of the three FB compounds increased
Table 1. Percent Recovery of 14C from 0.69 ímol of 14C-FB1, 14C-HFB1, and 14C-FB1-Fructose/kg Body Weight in Ratsa
percent dose
urine feces tissues recovery
total dose male female male female male female male female
FB1 0.4a 0.7a 85 95 0.28 2.72 86 99
HFB1 12.8c 17.3d 87 91 0.14 1.31 100 110
FB1-fructose 4.2b 4.6b 86 97 0.19 0.42 91 102
a Different superscripts indicate that the means were significantly different at R ) 0.05; n ) 3 per gender and treatment.
Figure 2. Urine excretion of 14C from 0.69 ímol of 14C-FB1,
14C-HFB1, and 14C-FB1-fructose/kg body weight by rats per
12-h interval. Error bars represent ( 1 standard deviation; n
) 6. Bars within a time interval with different superscripts
were different at R ) 0.05. FB1-FRU ) FB1-fructose.
Figure 3. Fecal excretion of 14C from 0.69 ímol of 14C-FB1,
14C-HFB1, and 14C-FB1-fructose/kg body weight by rats per
12-h interval. Error bars represent ( 1 standard deviation; n
) 6.
Table 2. Biliary Excretion of 14C from 0.69 ímol of
14C-FB1, 14C-HFB1, and 14C-FB1-Fructose/kg Body Weight
in Rats over 4 ha
dose percent excretion
FB1 1.55 ( 2.51
HFB1 1.71 ( 1.99
FB1-fructose 0.80 ( 0.82
a n ) 3.
4294 J. Agric. Food Chem., Vol. 47, No. 10, 1999 Dantzer et al.
from 0 to 0.5% of the total dose per 0.5-h interval within
2 h after dosing. The three forms of FB continued to be
excreted in the bile by the rats up to 9.5 h after dosing
(Figure 4). There seemed to be no cyclical nature to 14C
excretion in the bile after administration of the dose by
gavage. The large range seen in the biliary excretion
data suggest the presence of fluorescent compounds that
have been previously observed in rat bile (Hicks et al.,
1984). Only two rats from the 14C-FB1 dose and one rat
from the 14C-HFB1 and 14C-FB1-fructose doses survived
for 9.5 h. Shephard et al. (1994) recovered almost 7-fold
less, 0.2% of their total 14C dose in bile duct cannulated
rats gavaged with 14C-FB1 as compared to our rats. The
rats used by Shephard et al. (1994) were not under
anesthesia during gavage or bile collection. Half of the
14C dose of the three forms of FB1 were recovered in
the stomach tissue and contents of our rats (50 ( 23%
of the total dose), indicating that only about half of the
dosed-FB compounds could have reached the small
intestine of these rats (data not shown). Because these
rats were under anesthesia throughout the duration of
the experiment, there may have been a slower rate of
absorption as compared with Shephard et al. (1994). The
pooled intestines and bile samples from the rats con-
tained 3 ( 6 and 3 ( 4% of the total dose, respectively.
Kidneys and livers contained less than 1% of the 14C
dose. Total recovery of the 14C doses from these rats of
the bile excretion study averaged 63 ( 17%.
The 25-fold greater absorption of 14C-HFB1 than that
of 14C-FB1 in male and female Fisher rats suggested
that, once in circulation, HFB1 was less toxic than FB1,
on a molar basis, because both have been shown to be
equally toxic on a dietary basis to rats (Hendrich et al.,
1993). Detoxification of FB1 by the formation of FB1-
fructose was not the result of decreased absorption since
14C-FB1-fructose was absorbed 8-fold more than 14C-FB1
by these rats. These data complement and extend the
findings of Hopmans et al. (1997), suggesting that HFB1
or FB1-fructose were absorbed more than FB1. In
addition, there were no differences in biliary excretion
of 14C-FB1, 14C-HFB1, or 14C-FB1-fructose in female
Sprague-Dawley rats, lending additional support to the
likelihood that the observed decrease in urinary excre-
tion of FB1 as compared with HFB1 or FB1-fructose was
due to decreased absorption of FB1 relative to HFB1 or
FB1-fructose in rats.
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